Top 20 global biopharmaceutical firms experience varied market capitalisation shifts in Q3 2023: GlobalData, ET HealthWorld
![Worst deal ever? Bayer's market cap now close to the total cost it paid for Monsanto | Fierce Pharma Worst deal ever? Bayer's market cap now close to the total cost it paid for Monsanto | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1567092636/bayer-office-building-socialmedia-1200x630.jpg/bayer-office-building-socialmedia-1200x630.jpg?VersionId=hZIMJuRfUw5veSXuec1Y6q3p7hU_80Ze)
Worst deal ever? Bayer's market cap now close to the total cost it paid for Monsanto | Fierce Pharma
![Top 20 global biopharmaceutical companies by market capitalization (quarter ended March 31, 2022), presented by GlobalData - GlobalData Top 20 global biopharmaceutical companies by market capitalization (quarter ended March 31, 2022), presented by GlobalData - GlobalData](https://eu.vocuspr.com/Publish/3434416/vcsPRAsset_3434416_152867_e4c0333c-75ea-4f1c-980f-89a5fd811bc4_0.png)
Top 20 global biopharmaceutical companies by market capitalization (quarter ended March 31, 2022), presented by GlobalData - GlobalData
![GlobalData's Top 20 global pharmaceutical companies by market cap (year ended December 31, 2018) - GlobalData GlobalData's Top 20 global pharmaceutical companies by market cap (year ended December 31, 2018) - GlobalData](https://eu.vocuspr.com/Publish/3434416/vcsPRAsset_3434416_101379_2e746a63-4a5f-4c53-a839-000a1e75a721_0.png)